U3REP220673
Cooperative Agreement
Overview
Grant Description
Regional Emerging Special Pathogen Treatment Center
Emory University and Children's Healthcare of Atlanta
The purpose of this proposal is for the awardee, Emory University, in collaboration with Children's Healthcare of Atlanta-Egleston, to support the HHS Administration for Strategic Preparedness and Response by maintaining an Emerging Special Pathogens Treatment Center (RESPTC) for Region 4. The biocontainment unit at Emory University Hospital is supported by all of Emory Healthcare in partnership with Emory University.
The expected outcomes of this project are to:
- Serve as regional leaders in developing, disseminating, and maintaining standards, guidance, and promising practices for high-quality, coordinated special pathogen care and for decision-making during a special pathogen outbreak.
- Build capacity for the National Special Pathogen System (NSPS) to accelerate special pathogen research, serving as a regional hub to conduct, participate in, and share insights related to special pathogen and clinical trial research.
- Maintain a trained, diverse, and specialized workforce across their region and the NSPS, serve as a regional leader in providing special pathogen trainings, explore innovative and flexible healthcare workforce solutions, and share resources and promising practices to develop and maintain workforce capabilities to respond to special pathogen surge events.
As the first biocontainment unit in the US, the first hospital to care for patients with Ebola, one of the leading institutions for the National Emerging Special Pathogens Training and Education Center, and a designated RESPTC since 2015, Emory is well-positioned to remain the Region IV RESPTC.
In addition to the RESPTC assets curated since the creation of the Serious Communicable Diseases Unit, Emory also serves as the Southeastern Regional Disaster Health Response System.
Emory University and Children's Healthcare of Atlanta
The purpose of this proposal is for the awardee, Emory University, in collaboration with Children's Healthcare of Atlanta-Egleston, to support the HHS Administration for Strategic Preparedness and Response by maintaining an Emerging Special Pathogens Treatment Center (RESPTC) for Region 4. The biocontainment unit at Emory University Hospital is supported by all of Emory Healthcare in partnership with Emory University.
The expected outcomes of this project are to:
- Serve as regional leaders in developing, disseminating, and maintaining standards, guidance, and promising practices for high-quality, coordinated special pathogen care and for decision-making during a special pathogen outbreak.
- Build capacity for the National Special Pathogen System (NSPS) to accelerate special pathogen research, serving as a regional hub to conduct, participate in, and share insights related to special pathogen and clinical trial research.
- Maintain a trained, diverse, and specialized workforce across their region and the NSPS, serve as a regional leader in providing special pathogen trainings, explore innovative and flexible healthcare workforce solutions, and share resources and promising practices to develop and maintain workforce capabilities to respond to special pathogen surge events.
As the first biocontainment unit in the US, the first hospital to care for patients with Ebola, one of the leading institutions for the National Emerging Special Pathogens Training and Education Center, and a designated RESPTC since 2015, Emory is well-positioned to remain the Region IV RESPTC.
In addition to the RESPTC assets curated since the creation of the Serious Communicable Diseases Unit, Emory also serves as the Southeastern Regional Disaster Health Response System.
Awardee
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
California
United States
Geographic Scope
State-Wide
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 436% from $1,200,000 to $6,430,768.
Emory University was awarded
Region 4 RESPTC: Special Pathogen Treatment Hub
Cooperative Agreement U3REP220673
worth $6,430,768
from the HHS Office of the Assistant Secretary for Preparedness and Response in September 2022 with work to be completed primarily in California United States.
The grant
has a duration of 5 years and
was awarded through assistance program 93.825 National Ebola Training and Education Center (NETEC).
The Cooperative Agreement was awarded through grant opportunity Regional Ebola and Other Special Pathogen Treatment Centers.
Status
(Ongoing)
Last Modified 1/21/25
Period of Performance
9/30/22
Start Date
9/29/27
End Date
Funding Split
$6.4M
Federal Obligation
$0.0
Non-Federal Obligation
$6.4M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for U3REP220673
Transaction History
Modifications to U3REP220673
Additional Detail
Award ID FAIN
U3REP220673
SAI Number
U3REP220673-3322284213
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Awarding Office
75APRR ASPR OFFICE OF RESOURCE MANAGEMENT
Funding Office
75AN00 ASPR ADMINISTRATION FOR STRATEGIC PREPAREDNESS AND RESPONSE
Awardee UEI
S352L5PJLMP8
Awardee CAGE
2K291
Performance District
CA-90
Senators
Dianne Feinstein
Alejandro Padilla
Alejandro Padilla
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| Public Health and Social Services Emergency Fund, Office of the Secretary, Health and Human Services (075-0140) | Health care services | Grants, subsidies, and contributions (41.0) | $2,815,384 | 100% |
Modified: 1/21/25